{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:35:13Z","timestamp":1779089713467,"version":"3.51.4"},"reference-count":48,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1620\/tjem.237.9","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T22:02:42Z","timestamp":1439848962000},"page":"9-15","source":"Crossref","is-referenced-by-count":5,"title":["Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus"],"prefix":"10.1620","volume":"237","author":[{"given":"Ryu","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abu-Shakra, M., El-Sana, S., Margalith, M., Sikuler, E., Neumann, L. &amp; Buskila, D. (1997) Hepatitis B and C viruses serology in patients with SLE. <i>Lupus<\/i>, 6, 543-544.","DOI":"10.1177\/096120339700600612"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Agmon-Levin, N., Arango, M.T., Kivity, S., Katzav, A., Gilburd, B., Blank, M., Tomer, N., Volkov, A., Barshack, I., Chapman, J. &amp; Shoenfeld, Y. (2014) Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. <i>J. Autoimmun.<\/i>, 54, 21-32.","DOI":"10.1016\/j.jaut.2014.06.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Aron-Maor, A. &amp; Shoenfeld, Y. (2001) Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. <i>Lupus<\/i>, 10, 237-240.","DOI":"10.1191\/096120301673085478"},{"key":"4","unstructured":"Aytac, M.B., Kasapcopur, O., Aslan, M., Erener-Ercan, T., Cullu-Cokugras, F. &amp; Arisoy, N. (2011) Hepatitis B vaccination in juvenile systemic lupus erythematosus. <i>Clin. Exp. Rheumatol.<\/i>, 29, 882-886."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bessone, F., Poles, N. &amp; Roma, M.G. (2014) Challenge of liver disease in systemic lupus erythematosus: clues for diagnosis and hints for pathogenesis. <i>World J. Hepatol.<\/i>, 6, 394-409.","DOI":"10.4254\/wjh.v6.i6.394"},{"key":"6","unstructured":"Bonafede, R.P., van Staden, M. &amp; Klemp, P. (1986) Hepatitis B virus infection and liver function in patients with systemic lupus erythematosus. <i>J. Rheumatol.<\/i>, 13, 1050-1052."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Boyman, O., Comte, D. &amp; Spertini, F. (2014) Adverse reactions to biologic agents and their medical management. <i>Nat. Rev. Rheumatol.<\/i>, 10, 612-627.","DOI":"10.1038\/nrrheum.2014.123"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Charpin, C., Guis, S., Colson, P., Borentain, P., Mattei, J.P., Alcaraz, P., Balandraud, N., Thomachot, B., Roudier, J. &amp; Gerolami, R. (2009) Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients. <i>Arthritis Res. Ther.<\/i>, 11, R179.","DOI":"10.1186\/ar2868"},{"key":"9","unstructured":"Chng, H.H., Fock, K.M., Chew, C.N., Guan, R., Feng, P.H., Boey, M.L., Chee, E.N. &amp; Chua, K.L. (1993) Hepatitis B virus infection in patients with systemic lupus erythematosus. <i>Singapore Med. J.<\/i>, 34, 325-326."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Chowdhary, V.R., Crowson, C.S., Poterucha, J.J. &amp; Moder, K.G. (2008) Liver involvement in systemic lupus erythematosus: case review of 40 patients. <i>J. Rheumatol.<\/i>, 35, 2159-2164.","DOI":"10.3899\/jrheum.080336"},{"key":"11","unstructured":"Geier, M.R. &amp; Geier, D.A. (2004) A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. <i>Clin. Exp. Rheumatol.<\/i>, 22, 749-755."},{"key":"12","doi-asserted-by":"crossref","unstructured":"Harigai, M., Mochida, S., Mimura, T., Koike, T. &amp; Miyasaka, N. (2014) A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy. <i>Mod. Rheumatol.<\/i>, 24, 1-7.","DOI":"10.3109\/14397595.2013.852834"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Her, M., Lee, Y., Jung, E., Kim, T. &amp; Kim, D. (2011) Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis. <i>Rheumatol. Int.<\/i>, 31, 79-84.","DOI":"10.1007\/s00296-009-1237-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. <i>Arthritis Rheum.<\/i>, 40, 1725.","DOI":"10.1002\/art.1780400928"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Huang, D., Aghdassi, E., Su, J., Mosko, J., Hirschfield, G.M., Gladman, D.D., Urowitz, M.B. &amp; Fortin, P.R. (2012) Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. <i>J. Rheumatol.<\/i>, 39, 254-261.","DOI":"10.3899\/jrheum.110310"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hui, C.K., Cheung, W.W., Zhang, H.Y., Au, W.Y., Yueng, Y.H., Leung, A.Y., Leung, N., Luk, J.M., Lie, A.K., Kwong, Y.L., Liang, R. &amp; Lau, G.K. (2006) Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. <i>Gastroenterology<\/i>, 131, 59-68.","DOI":"10.1053\/j.gastro.2006.04.015"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kuruma, K.A., Borba, E.F., Lopes, M.H., de Carvalho, J.F. &amp; Bonfa, E. (2007) Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. <i>Lupus<\/i>, 16, 350-354.","DOI":"10.1177\/0961203307078225"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kusumoto, S., Tanaka, Y., Mizokami, M. &amp; Ueda, R. (2009) Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. <i>Int. J. Hematol.<\/i>, 90, 13-23.","DOI":"10.1007\/s12185-009-0359-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kwak, M.S. &amp; Kim, Y.J. (2014) Occult hepatitis B virus infection. <i>World J. Hepatol.<\/i>, 6, 860-869.","DOI":"10.4254\/wjh.v6.i12.860"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lee, W.M. (1997) Hepatitis B virus infection. <i>N. Engl. J. Med.<\/i>, 337, 1733-1745.","DOI":"10.1056\/NEJM199712113372406"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Looi, L.M. &amp; Prathap, K. (1982) Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. <i>Histopathology<\/i>, 6, 141-147.","DOI":"10.1111\/j.1365-2559.1982.tb02711.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Lu, C.L., Tsai, S.T., Chan, C.Y., Hwang, S.J., Tsai, C.Y., Wu, J.C., Lu, R.H., Lin, B.C. &amp; Lee, S.D. (1997) Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan. <i>J. Gastroenterol. Hepatol.<\/i>, 12, 272-276.","DOI":"10.1111\/j.1440-1746.1997.tb00420.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Millet, A., Decaux, O., Perlat, A., Grosbois, B. &amp; Jego, P. (2009) Systemic lupus erythematosus and vaccination. <i>Eur. J. Intern. Med.<\/i>, 20, 236-241.","DOI":"10.1016\/j.ejim.2008.07.017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Mori, S. (2011) Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and\/or nonbiological disease-modifying antirheumatic drugs. <i>Mod. Rheumatol.<\/i>, 21, 621-627.","DOI":"10.3109\/s10165-011-0458-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M.A., Kuhn, A., Gordon, C., Petri, M., Rekvig, O.P., Schneider, M., et al. (2010) European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. <i>Ann. Rheum. Dis.<\/i>, 69, 1269-1274.","DOI":"10.1136\/ard.2009.117200"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Oketani, M., Ido, A., Uto, H. &amp; Tsubouchi, H. (2012) Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy. <i>Hepatol. Res.<\/i>, 42, 627-636.","DOI":"10.1111\/j.1872-034X.2012.00998.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Onozawa, M., Hashino, S., Izumiyama, K., Kahata, K., Chuma, M., Mori, A., Kondo, T., Toyoshima, N., Ota, S., Kobayashi, S., Hige, S., Toubai, T., Tanaka, J., Imamura, M. &amp; Asaka, M. (2005) Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. <i>Transplantation<\/i>, 79, 616-619.","DOI":"10.1097\/01.TP.0000151661.52601.FB"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Permin, H., Aldershvile, J. &amp; Nielsen, J.O. (1982) Hepatitis B virus infection in patients with rheumatic diseases. <i>Ann. Rheum. Dis.<\/i>, 41, 479-482.","DOI":"10.1136\/ard.41.5.479"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Petri, M., Kim, M.Y., Kalunian, K.C., Grossman, J., Hahn, B.H., Sammaritano, L.R., Lockshin, M., Merrill, J.T., Belmont, H.M., Askanase, A.D., McCune, W.J., Hearth-Holmes, M., Dooley, M.A., Von Feldt, J., Friedman, A., et al. (2005) Combined oral contraceptives in women with systemic lupus erythematosus. <i>N. Engl. J. Med.<\/i>, 353, 2550-2558.","DOI":"10.1056\/NEJMoa051135"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Ram, M., Anaya, J.M., Barzilai, O., Izhaky, D., Porat Katz, B.S., Blank, M. &amp; Shoenfeld, Y. (2008) The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. <i>Autoimmun. Rev.<\/i>, 7, 621-625.","DOI":"10.1016\/j.autrev.2008.06.008"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Singh, J.A., Furst, D.E., Bharat, A., Curtis, J.R., Kavanaugh, A.F., Kremer, J.M., Moreland, L.W., O\u2019Dell, J., Winthrop, K.L., Beukelman, T., Bridges, S.L. Jr., Chatham, W.W., Paulus, H.E., Suarez-Almazor, M., Bombardier, C., et al. (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. <i>Arthritis Care Res.<\/i>, 64, 625-639.","DOI":"10.1002\/acr.21641"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Takahashi, A., Abe, K., Saito, R., Iwadate, H., Okai, K., Katsushima, F., Monoe, K., Kanno, Y., Saito, H., Kobayashi, H., Watanabe, H. &amp; Ohira, H. (2013) Liver dysfunction in patients with systemic lupus erythematosus. <i>Intern. Med.<\/i>, 52, 1461-1465.","DOI":"10.2169\/internalmedicine.52.9458"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Takahashi, A., Abe, K., Yokokawa, J., Iwadate, H., Kobayashi, H., Watanabe, H., Irisawa, A. &amp; Ohira, H. (2010) Clinical features of liver dysfunction in collagen diseases. <i>Hepatol. Res.<\/i>, 40, 1092-1097.","DOI":"10.1111\/j.1872-034X.2010.00707.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Trepo, C., Chan, H.L. &amp; Lok, A. (2014) Hepatitis B virus infection. <i>Lancet<\/i>, 384, 2053-2063.","DOI":"10.1016\/S0140-6736(14)60220-8"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Tsokos, G.C. (2011) Systemic lupus erythematosus. <i>N. Engl. J. Med.<\/i>, 365, 2110-2121.","DOI":"10.1056\/NEJMra1100359"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Tur-Kaspa, R. &amp; Laub, O. (1990) Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. <i>J. Hepatol.<\/i>, 11, 34-36.","DOI":"10.1016\/0168-8278(90)90268-V"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Umemura, T., Tanaka, E., Kiyosawa, K., Kumada, H.; Japan de novo Hepatitis B Research Group (2008) Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. <i>Clin. Infect. Dis.<\/i>, 47, e52-56.","DOI":"10.1086\/590968"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Urata, Y., Uesato, R., Tanaka, D., Kowatari, K., Nitobe, T., Nakamura, Y. &amp; Motomura, S. (2011) Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients. <i>Mod. Rheumatol.<\/i>, 21, 16-23.","DOI":"10.3109\/s10165-010-0337-z"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Vassilopoulos, D. &amp; Calabrese, L.H. (2012) Management of rheumatic disease with comorbid HBV or HCV infection. <i>Nat. Rev. Rheumatol.<\/i>, 8, 348-357.","DOI":"10.1038\/nrrheum.2012.63"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Wands, J.R., Chura, C.M., Roll, F.J. &amp; Maddrey, W.C. (1975) Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. <i>Gastroenterology<\/i>, 68, 105-112.","DOI":"10.1016\/S0016-5085(75)80054-0"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Wang, Z., Li, M., Zeng, X. &amp; Liu, X. (2012) Hepatitis B virus-associated antigen deposition in renal tissue from patients with systemic lupus erythematosus. <i>J. Rheumatol.<\/i>, 39, 974-978.","DOI":"10.3899\/jrheum.111107"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Watanabe, R., Ishii, T., Kobayashi, H., Asahina, I., Takemori, H., Izumiyama, T., Oguchi, Y., Urata, Y., Nishimaki, T., Chiba, K., Komatsuda, A., Chiba, N., Miyata, M., Takagi, M., Kawamura, O., et al. (2014) Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey. <i>Tohoku J. Exp. Med.<\/i>, 233, 129-133.","DOI":"10.1620\/tjem.233.129"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Watanabe, R., Ishii, T., Nakamura, K., Shirai, T., Tajima, Y., Fujii, H. &amp; Harigae, H. (2013) Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy. <i>Mod. Rheumatol.<\/i>, 23, 1094-1100.","DOI":"10.3109\/s10165-012-0797-4"},{"key":"44","unstructured":"Weinbaum, C.M., Williams, I., Mast, E.E., Wang, S.A., Finelli, L., Wasley, A., Neitzel, S.M., Ward, J.W.; Centers for Disease Control and Prevention (CDC) (2008) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. <i>MMWR Recomm. Rep.<\/i>, 57, 1-20."},{"key":"45","doi-asserted-by":"crossref","unstructured":"Yeo, W. &amp; Johnson, P.J. (2006) Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. <i>Hepatology<\/i>, 43, 209-220.","DOI":"10.1002\/hep.21051"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Youssef, W.I. &amp; Tavill, A.S. (2002) Connective tissue diseases and the liver. <i>J. Clin. Gastroenterol.<\/i>, 35, 345-349.","DOI":"10.1097\/00004836-200210000-00012"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Yuki, N., Nagaoka, T., Yamashiro, M., Mochizuki, K., Kaneko, A., Yamamoto, K., Omura, M., Hikiji, K. &amp; Kato, M. (2003) Long-term histologic and virologic outcomes of acute self-limited hepatitis B. <i>Hepatology<\/i>, 37, 1172-1179.","DOI":"10.1053\/jhep.2003.50171"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Zhao, J., Qiu, M., Li, M., Lu, C. &amp; Gu, J. (2010) Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. <i>Rheumatol. Int.<\/i>, 30, 1565-1570.","DOI":"10.1007\/s00296-009-1188-9"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/237\/1\/237_9\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T08:13:29Z","timestamp":1599466409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/237\/1\/237_9\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.237.9","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}